| US4053626A
              (en)
            
            * | 1973-03-13 | 1977-10-11 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Cholesterol level-lowering phenoxyacetic acids | 
        
          | PT656786E
              (pt)
            
            * | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo | 
        
          | US5446061A
              (en)
            
            * | 1993-11-05 | 1995-08-29 | Eli Lilly And Company | Methods for lowering serum cholesterol | 
        
          | US5407955A
              (en)
            
            * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease | 
        
          | US5446071A
              (en)
            
            * | 1994-11-18 | 1995-08-29 | Eli Lilly And Company | Methods for lowering serum cholesterol | 
        
          | JPH10511961A
              (ja)
            
            * | 1995-01-13 | 1998-11-17 | ノボ  ノルディスク  アクティーゼルスカブ | 高リポプロテイン血症、高トリグリセリド血症、高脂血症又は高コレステロール血症の治療又は予防のための、又は抗血液凝固処置のための医薬組成物の製造のための3,4−ジフェニル・クロマンの使用 | 
        
          | BE1010487A6
              (nl) | 1996-06-11 | 1998-10-06 | Unilin Beheer Bv | Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen. | 
        
          | AUPO203996A0
              (en)
            
            * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses | 
        
          | US5958967A
              (en)
            
            * | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | US6043269A
              (en)
            
            * | 1996-10-28 | 2000-03-28 | Novo Nordisk A/S | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | US5985306A
              (en)
            
            * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes | 
        
          | CA2270057A1
              (en)
            
            * | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | JP2001502709A
              (ja)
            
            * | 1996-10-28 | 2001-02-27 | ノボ  ノルディスク  アクティーゼルスカブ | エストロゲン関連疾患または症候群の予防または治療に有用な新規なシス―3,4―クロマン誘導体 | 
        
          | US5994390A
              (en)
            
            * | 1996-10-28 | 1999-11-30 | Novo Nordisk | Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | WO1998018778A1
              (en)
            
            * | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | AU4699897A
              (en)
            
            * | 1996-10-28 | 1998-05-22 | Novo Nordisk A/S | Novel (-)-enantiomers of (cis)-3,4-chroman derivatives useful in the preve ntion or treatment of estrogen related diseases or syndromes | 
        
          | US6316494B1
              (en) | 1996-10-28 | 2001-11-13 | Novo Nordisk A/S | cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | CA2270113A1
              (en)
            
            * | 1996-10-28 | 1998-05-07 | Poul Jacobsen | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | US5919817A
              (en)
            
            * | 1996-10-28 | 1999-07-06 | Novo Nordisk A/S | Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | AU744403B2
              (en)
            
            * | 1996-10-28 | 2002-02-21 | Novo Nordisk A/S | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | CA2269973A1
              (en)
            
            * | 1996-10-28 | 1998-05-07 | Paul Stanley Bury | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | ZA979644B
              (en)
            
            * | 1996-10-28 | 1998-04-28 | Novo Nordisk As | Heterocyclic compounds, compositions and uses. | 
        
          | WO1998018776A1
              (en)
            
            * | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | 
        
          | US6146668A
              (en) | 1997-04-28 | 2000-11-14 | Novogen, Inc. | Preparation of isoflavones from legumes | 
        
          | EP0979074A4
              (en)
            
            * | 1997-05-01 | 2003-07-09 | Novogen Inc | TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS | 
        
          | AUPP112497A0
              (en)
            
            * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage | 
        
          | AUPP260798A0
              (en) | 1998-03-26 | 1998-04-23 | Novogen Research Pty Ltd | Treatment of medical related conditions with isoflavone containing extracts of clover | 
        
          | KR20000001793A
              (ko) | 1998-06-13 | 2000-01-15 | 이경하 | 신규한 벤조피란 또는 티오벤조피란 유도체 | 
        
          | AUPP868599A0
              (en)
            
            * | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives | 
        
          | AUPQ266199A0
              (en)
            
            * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof | 
        
          | US20090233999A1
              (en)
            
            * | 1999-09-06 | 2009-09-17 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof | 
        
          | AUPQ520300A0
              (en)
            
            * | 2000-01-21 | 2000-02-17 | Novogen Research Pty Ltd | Food product and process | 
        
          | AU2001256164A1
              (en) | 2000-03-01 | 2001-09-12 | Akzo Nobel N.V. | Chroman derivatives as estrogenic compounds | 
        
          | AUPR363301A0
              (en)
            
            * | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones | 
        
          | US20050119301A1
              (en)
            
            * | 2001-03-16 | 2005-06-02 | Alan Husband | Treatment of restenosis | 
        
          | CN1902213B
              (zh)
            
            * | 2003-11-18 | 2010-06-23 | 诺沃根研究股份有限公司 | 异黄酮类前药、其组合物和涉及它们的治疗方法 | 
        
          | AU2004290613B2
              (en)
            
            * | 2003-11-18 | 2010-03-25 | Novogen Research Pty Ltd | Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same | 
        
          | ATE532777T1
              (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie | 
        
          | US8080675B2
              (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy | 
        
          | JP6013349B2
              (ja) | 2010-11-01 | 2016-10-25 | メイ ファーマ, インク.Mei Pharma, Inc. | 癌の処置のためのイソフラボノイド化合物および方法 | 
        
          | CN116139125A
              (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |